<DOC>
	<DOCNO>NCT00862888</DOCNO>
	<brief_summary>The purpose study investigate effect 200 mg PF-00446687 erectile activity male suffer erectile dysfunction well examine safety toleration drug .</brief_summary>
	<brief_title>Study Investigate Effect New Drug ( PF-00446687 ) Males Suffering From Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Males age 1865 year give write informed consent participate study suffers moderate severe erectile dysfunction current recent successful response treatment phosphodiesterase type 5 inhibitor Males history significant cardiac disease ; unstable angina recent myocardial infarction . Males suffer treat untreated hypo hypertension Males currently receive vasoactive medication Males take medication contraindicate , caution sildenafil MC4 agonist</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>